Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human OPRD1 Antibodies:
anti-Rat (Rattus) OPRD1 Antibodies:
anti-Mouse (Murine) OPRD1 Antibodies:
Go to our pre-filtered search.
Mouse (Murine) Polyclonal OPRD1 Primary Antibody for ICC, IF - ABIN250449
Ko, Arvidsson, Williams, Law, Elde, Loh: Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure. in Brain research. Molecular brain research 1999
Show all 3 Pubmed References
Human Polyclonal OPRD1 Primary Antibody for WB - ABIN2690091
Wu, Li, Wu: The effect of chronic intermittent hypoxia on respiratory sensitivity to morphine in rats. in Sleep & breathing = Schlaf & Atmung 2017
A polymorphism in OPRD1 appears to be associated with both cocaine dependence and cocaine use during treatment in African-Americans. Follow-up studies to confirm the effect on cocaine use are warranted.
OPRD1 promoter hypermethylation is associated with the risk of AD
After inhibition of the PKC/ERK signalling pathway, the effects of DOR on breast cancer were significantly attenuated in vivo and in vitro. In summary, DOR is highly expressed in breast cancer and is closely related to its progression. These results suggest that DOR may serve as a potential biomarker for the early diagnosis of breast cancer and may be a viable molecular target for therapeutic intervention.
The study successfully developed a population PKPD model for oxycodone across three experimental pain types and investigated the association between 18 SNPs across all three opioid receptor genes (OPRM1 (show OPRM1 Antibodies), OPRK1 (show OPRK1 Antibodies), OPRD1) and analgesic response from oxycodone. None of the selected polymorphisms were significantly associated with analgesic response of oxycodone.
the expression of DOR was upregulated in the drugresistant human hepatocellular carcinoma cells.
OPRD-mediated activation of ERK1/2 (show MAPK1/3 Antibodies) is via ligand-specific transactivation of EGFR (show EGFR Antibodies).
findings suggest that SNPs in opioid receptors and the PNOC (show PNOC Antibodies) genes are associated with NAS (show SCN9A Antibodies) severity.
TMED6-COG8 (show COG8 Antibodies) chimera might act as a novel diagnostic marker in TFE3 (show TFE3 Antibodies) translocation renal cell carcinoma (show MOK Antibodies).
We have established a delta opioid receptor-PKC (show PRRT2 Antibodies)-Nrf2 (show GABPA Antibodies) axis as a part of the mechanism underlying cytoprotection against hypoxia/reoxygenation injury
Targeted silencing of components of lobe B of the COG (show TG Antibodies) complex, namely COG5 (show COG5 Antibodies), COG6 (show COG6 Antibodies), COG7 (show COG7 Antibodies) and COG8 (show COG8 Antibodies), inhibited HIV-1 replication
Delta opioid receptor (DOR) expressed in the forebrain mediate the described locomotor effect of SNC80 (DOR agonist) and inhibit D1-stimulated hyperactivity. Data also reveals an anxiogenic role for this particular DOR subpopulation.
Anti-nociception mediated by a KOR agonist is blocked by a DOR agonist
we have demonstrated for the first time that DOR receptor activation induces astrocytic expression of EAAT1 (show SLC1A3 Antibodies) and EAAT2 (show SLC1A2 Antibodies)
The results of this study indicated that delta-opioid receptor have a differential role in cue-induced reinstatement of cocaine-seeking behavior.
findings show that, during prolonged heroin abstinence, delta opioid receptors regulate hedonic homeostasis, while mu opioid receptor (show OPRM1 Antibodies) signaling in serotonergic pathways and kappa opioid receptors together control social behaviors
a role for differential modulation of opioid receptor signaling by post-endocytic processing of peptide agonists by ECE2 (show ECE2 Antibodies).
SSTR4 and delta-Opioid receptor (dOR) exist in a heteromeric complex and function in synergistic manner.
Our study suggests that MOR(mu opioid receptors) and DOR(delta opioid receptors are involved in the interactions between cocaine and both deltorphins analogs
prolonged hypoxia down-regulates BDNF (show BDNF Antibodies)-TrkB (show NTRK2 Antibodies) signaling leading to an increase in TNF-alpha (show TNF Antibodies) in the cortex, while delta-opioid receptor activation up-regulates BDNF (show BDNF Antibodies)-TrkB (show NTRK2 Antibodies) signaling thereby decreasing TNF-alpha (show TNF Antibodies) levels in the hypoxic cortex.
This gene encodes a protein that is a component of the conserved oligomeric Golgi (COG) complex, a multiprotein complex that plays a structural role in the Golgi apparatus, and is involved in intracellular membrane trafficking and glycoprotein modification. Mutations in this gene cause congenital disorder of glycosylation, type IIh, a disease that is characterized by under-glycosylated serum proteins, and whose symptoms include severe psychomotor retardation, failure to thrive, seizures, and dairy and wheat product intolerance.
COG complex subunit 8
, conserved oligomeric Golgi complex subunit 8
, conserved oligomeric golgi complex component 8
, dependent on RIC1
, delta-type opioid receptor
, opioid receptor A
, delta opioid receptor 1
, delta 1 opioid receptor
, Delta-type opioid receptor
, delta opioid receptor